MANCINI, NICASIO
 Distribuzione geografica
Continente #
EU - Europa 1.228
NA - Nord America 790
AS - Asia 514
SA - Sud America 10
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.556
Nazione #
US - Stati Uniti d'America 786
SE - Svezia 574
IT - Italia 361
CN - Cina 243
SG - Singapore 230
RU - Federazione Russa 156
FI - Finlandia 40
IE - Irlanda 34
DE - Germania 29
IN - India 13
IR - Iran 9
NL - Olanda 7
SA - Arabia Saudita 7
PH - Filippine 6
RO - Romania 6
AU - Australia 5
BR - Brasile 5
HU - Ungheria 5
CL - Cile 4
FR - Francia 4
CA - Canada 3
CM - Camerun 3
A1 - Anonimo 2
BE - Belgio 2
CH - Svizzera 2
EU - Europa 2
GB - Regno Unito 2
HK - Hong Kong 2
PL - Polonia 2
TW - Taiwan 2
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HR - Croazia 1
JP - Giappone 1
MX - Messico 1
NG - Nigeria 1
PK - Pakistan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 2.556
Città #
Princeton 153
Lawrence 150
Singapore 145
Milan 135
Shanghai 125
Ashburn 114
New York 78
Moscow 77
Helsinki 37
Dublin 31
Boardman 27
Rome 27
Guangzhou 15
Florence 12
Shenzhen 12
Los Angeles 11
Seattle 10
Beijing 9
Dallas 9
Turin 9
Jiaxing 8
Pune 8
Washington 8
Bologna 7
Jeddah 6
Tehran 6
Bari 5
Budapest 5
Xi'an 5
Ancona 4
Busto Arsizio 4
Catania 4
Fremont 4
Quezon City 4
Santa Clara 4
Santiago 4
Ballincollig 3
Bergamo 3
Ferrara 3
Frankfurt Am Main 3
Genoa 3
Lansing 3
Melbourne 3
Nanjing 3
Naples 3
Palermo 3
Riccione 3
Rockville 3
Sorocaba 3
South San Francisco 3
Trieste 3
Varese 3
Vittoria 3
Albavilla 2
Ascoli Piceno 2
Borås 2
Brescia 2
Brugherio 2
Cagliari 2
Campi Bisenzio 2
Cento 2
Cologne 2
Como 2
Gatchina 2
Ghent 2
Hangzhou 2
Jamshedpur 2
Kassel 2
Kunming 2
Lappeenranta 2
Las Vegas 2
Latina 2
Paris 2
Pisa 2
Pontedera 2
Portland 2
Rosarno 2
Santa Croce sull'Arno 2
Sydney 2
São Paulo 2
Taipei 2
Tongling 2
Udine 2
Varedo 2
Verona 2
Wuxi 2
Zurich 2
Abuja 1
Amsterdam 1
Andover 1
Arezzo 1
Bacoor 1
Bengaluru 1
Bloemfontein 1
Buronzo 1
Cantù 1
Carugate 1
Central 1
Changzhi 1
Charlottesville 1
Totale 1.404
Nome #
A modified Frosch approach for posterior tibial plateau fractures: Technical note and case series 168
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 38
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 35
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 33
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 32
Biobanking for COVID-19 research 30
A Biologically-validated HCV E1E2 Heterodimer Structural Model 30
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 29
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 27
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 27
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 27
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 26
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 26
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 25
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 25
Answer to Photo Quiz: Scolecobasidium sp 24
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 23
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 23
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 23
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 23
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 23
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 22
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 22
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 22
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 22
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 22
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 21
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 21
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 21
Viral Respiratory Pathogens and Lung Injury 21
The interferon landscape along the respiratory tract impacts the severity of COVID-19 21
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 21
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 20
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 20
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 20
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 20
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 20
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 20
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 20
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 20
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 19
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 19
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 19
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 19
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 19
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 19
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 19
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 19
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 19
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 19
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 18
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 18
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 18
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 18
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 18
Coronaviridae and SARS-associated coronavirus strain HSR1 18
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 18
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection 18
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 18
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 18
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples 18
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 17
A closer look at prion strains: Characterization and important implications 17
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 17
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 17
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 17
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 16
HCV E2 core structures and mAbs: something is still missing 16
Phage display for the production of human monoclonal antibodies against human pathogens 16
Semen infections in men with primary infertility in the real-life setting 16
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial 16
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 16
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 16
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 15
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 15
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 15
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 15
Role and potential therapeutic use of antibodies against herpetic infections 15
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 15
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- 15
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 15
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 15
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 15
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 14
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 14
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 14
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing 14
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs. 14
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 14
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 14
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 13
Beauveria bassiana Keratitis: A Case Series and Review of Literature 13
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 13
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 13
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 13
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer? 13
Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation 13
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 13
Totale 2.107
Categoria #
all - tutte 43.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 4 0 0 0 0 3
2020/202157 4 2 0 14 6 9 9 5 0 7 1 0
2021/2022142 3 7 20 29 13 7 13 9 4 10 6 21
2022/20231.082 350 259 98 15 22 127 62 65 49 7 14 14
2023/2024756 27 40 101 92 53 149 34 70 9 23 42 116
2024/2025655 314 65 68 111 97 0 0 0 0 0 0 0
Totale 2.830